A study released in the Archives of Surgery concludes that a type of weight-loss surgery, laparoscopic adjustable gastric banding, offers relatively poor long-term outcomes in extremely overweight patients.
A study released today in the Archives of Surgery concludes that a type of weight-loss surgery, laparoscopic adjustable gastric banding, offers relatively poor long-term outcomes in extremely overweight patients.
The findings come a few weeks after guidelines issued by the American Heart Association suggested that weight-loss surgery is an appropriate treatment for those with morbid obesity (defined as having a body mass index [BMI] greater than 40) and the US Food and Drug Administration approved use of an adjustable gastric banding device for patients with a BMI as low as 30 who also have an obesity-related condition, such as type 2 diabetes, hypertension, or sleep apnea.
In the Archives article, lead author Jacques Himpens, MD, of the European School of Laparoscopic Surgery, Saint Pierre University Hospital in Brussels, Belgium, and colleagues assessed 82 patients with morbid obesity, some of whom also had an obesity-related condition, who underwent laparoscopic adjustable gastric banding at least 12 years ago. Study participants reduced their excess weight by 42.8%, going from a mean BMI of 41.57 to 33.79. But the proportion having hypertension, type 2 diabetes, or sleep apnea had increased. Furthermore, 39% had experienced a major complication and 60% had undergone at least one additional surgery. Ultimately, nearly half had the banding device removed. Even so, 60% of patients said they were satisfied with the procedure’s results.